HDA UK Media And Political Bulletin – 11 October 2017

Media and Political Bulletin

11 October 2017

GIRP have released their Wholesale Brief for October. To view this brief, please click here.

Media Summary

October 2017 Price Concessions/NCSO

PSNC, 10 October 2017

The PSNC reports on the Department of Health’s list of price concessions for October. A full list of the medicines that have received price concessions can be found here. The PSNC has said that if wholesalers have any problems obtaining a Part VIII product or problems obtaining the product at the Drug Tariff price then they should report this issue to the PSNC using their online feedback form on the PSNC website.

The PSNC also highlighted that if wholesalers have been able to source the product, they should provide full details of the supplier and price paid. The PSNC will then investigate the extent of the problem and if appropriate discuss the issue with the Department of Health.

HM Treasury release a whitepaper on a new Customs Bill

HM Treasury, 10 October 2017

The whitepaper outlines the Government’s plans for legislating for the UK’s future

customs, VAT and excise regimes. The whitepaper sets out the government’s approach to legislating for a future customs regime, and to creating a framework that supports intra-European trade.

As well as providing for the implementation of a negotiated settlement with the EU, the Bill will provide for a range of other possible outcomes. The whitepaper therefore also sets out how the government would manage leaving the EU without an agreement on customs, in the event of no deal being reached.

Parliamentary Coverage

HM Treasury, 10 October 2017

HM Treasury have released a whitepaper on a proposed new Customs Bill. To view this whitepaper, please click here.

MHRA – Decision: suspended and revoked licences for manufacturers and wholesalers of medicines, 10 October 2017

The MHRA have updated their public list of companies in the UK who have had their licence to manufacture or wholesale medicines revoked or suspended. To view this list in full, please click here.

Full Coverage


October 2017 Price Concessions/NCSO

PSNC, 10 October 2017


The Department of Health has granted the following price concessions for October 2017:

Drug Pack size Price Concession
Amiloride 5mg tablets 28 £9.25
Amlodipine 5mg tablets 28 £3.75
Amlodipine 10mg tablets 28 £3.99
Anastrozole 1mg tablets 28 £14.45
Atorvastatin 80mg tablets 28 £2.40
Betahistine 8mg tablets 84 £5.06
Betahistine 16mg tablets 84 £8.50
Bicalutamide 50mg tablets 28 £1.90
Bicalutamide 150mg tablets 28 £6.50
Buspirone 10mg tablets 30 £9.00
Chlorpromazine 25mg tablets 28 £41.00
Chlorpromazine 50mg tablets 28 £41.00
Chlorpromazine 100mg tablets 28 £41.00
Citalopram 10mg tablets 28 £1.69
Citalopram 20mg tablets 28 £3.09
Citalopram 40mg tablets 28 £3.29
Colecalciferol 400unit capsules 28 £4.99
Dapsone 50mg tablets 28 £42.00
Duloxetine 20mg capsules 28 £8.95
Duloxetine 30mg capsules 28 £6.00
Duloxetine 40mg capsules 56 £10.50
Duloxetine 60mg capsules 28 £15.49
Enalapril 5mg tablets 28 £2.59
Enalapril 10mg tablets 28 £2.59
Enalapril 20mg tablets 28 £2.59
Eplerenone 25mg tablets 28 £42.72
Eplerenone 50mg tablets 28 £12.60
Exemestane 25mg tablets 30 £63.50
Gabapentin 300mg capsules 100 £13.95
Gabapentin 400mg capsules 100 £12.00
Gabapentin 600mg tablets 100 £7.20
Haloperidol 1.5mg tablets 28 £12.00
Hydroxychloroquine 200mg tablets 60 £16.50
Levetiracetam 250mg tablets 60 £28.01
Levetiracetam 750mg tablets 60 £61.50
Mefenamic 500mg tablets 28 £55.00
Olanzapine 10mg tablets 28 £62.00
Olanzapine 15mg tablets 28 £84.00
Olanzapine 2.5mg tablets 28 £16.00
Olanzapine 20mg tablets 28 £108.99
Olanzapine 5mg tablets 28 £31.00
Olanzapine 7.5mg tablets 28 £45.00
Oxazepam 10mg tablets 28 £19.97
Oxazepam 15mg tablets 28 £19.97
Pregabalin 150mg capsules 56 £8.50
Pregabalin 200mg capsules 84 £12.00
Pregabalin 225mg capsules 56 £8.95
Pregabalin 25mg capsules 56 £7.50
Pregabalin 300mg capsules 56 £8.96
Pregabalin 50mg capsules 84 £11.70
Pregabalin 75mg capsules 56 £7.75
Quetiapine 100mg tablets 60 £70.00
Quetiapine 150mg tablets 60 £72.00
Quetiapine 200mg tablets 60 £71.00
Quetiapine 25mg tablets 60 £24.95
Quetiapine 300mg tablets 60 £136.00
Rasagiline 1mg tablets 28 £13.95
Rizatriptan 10mg tablets 3 £13.37
Sodium Cromoglicate 2% eye drops 13.5ml £9.72
Sumatriptan 100mg tablets 6 £22.00
Sumatriptan 50mg tablets 6 £15.00
Terbinafine 250mg tablets 14 £12.49
Tramadol 50mg capsules 30 £1.20
Tramadol 50mg capsules 100 £3.20
Tranexamic Acid 500mg tablets 60 £14.30
Trimethoprim 50mg/5ml oral suspension SF 100ml £3.99
Valsartan 160mg capsules 28 £12.00
Valsartan 80mg capsules 28 £9.99
Vitamin B Co Strong tablets 28 £6.19
Zolmitriptan 2.5mg orodispersible tablets sugar free 6 £18.27
Zolmitriptan 2.5mg tablets 6 £18.00

Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession. No additional endorsements are required for price concessions. The price concession only applies to the month that it is granted.

If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.

If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health.

HDA UK Media And Political Bulletin – 11 October 2017

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?